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Major questions of neurological and psychiatric mechanisms involve the brain functions
on a molecular level and cannot be easily addressed due to limitations in access to tissue
samples. Post mortem studies are able to partly bridge the gap between brain tissue
research retrieved from animal trials and the information derived from peripheral analysis
(e.g., measurements in blood cells) in patients. Here, we wanted to know how fast DNA
degradation is progressing under controlled conditions in order to define thresholds for
tissue quality to be used in respective trials. Our focus was on the applicability of partly
degraded samples for bisulfite sequencing and the determination of simple means to
define cut-off values. After opening the brain cavity, we kept two consecutive pig skulls at
ambient temperature (19–21◦C) and removed cortex tissue up to a post mortem interval
(PMI) of 120 h. We calculated the percentage of degradation on DNA gel electrophoresis
of brain DNA to estimate quality and relate this estimation spectrum to the quality of
human post mortem control samples. Functional DNA quality was investigated by bisulfite
sequencing of two functionally relevant genes for either the serotonin receptor 5 (SLC6A4)
or aldehyde dehydrogenase 2 (ALDH2). Testing our approach in a heterogeneous
collective of human blood and brain samples, we demonstrate integrity of measurement
quality below the threshold of 72 h PMI. While sequencing technically worked for all
timepoints irrespective of conceivable DNA degradation, there is a good correlation
between variance of methylation to degradation levels documented in the gel (R2 =
0.4311, p = 0.0392) for advancing post mortem intervals (PMI). This otherwise elusive
phenomenon is an important prerequisite for the interpretation and evaluation of samples
prior to in-depth processing via an affordable and easy assay to estimate identical sample
quality and thereby comparable methylation measurements.
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Introduction
Investigating the brain and its molecular regulation is limited to either translational animal models
or post mortem investigations. Both approaches have their specific advantages and limitations.
Animal models reduce inter-individual variance and enable a strict observation of experimental
and environmental conditions, including the sacrifice of the animal. However, the translational
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value of certain pathologies, especially in the field of psychiatric
molecular research, is very limited. With post mortem studies
the possibilities for anamnesis are only limited by differences in
the evaluation of certain phenotypes by different psychiatrists,
but all life parameters such as age, drug treatment, agonal state
and cause of death are highly variable in comparison. Another
important caveat to consider is that, depending on the type
and progression of causality leading to death, the parameters
observed in the study might be seriously deregulated, since it
is widely accepted that epigenetic regulation, especially in the
context of drastic metabolic impacts, is altered in the range
of minutes to hours (McCullumsmith and Meador-Woodruff,
2011).
After the publication of epigenetic preservation of
methylation patterns in archeological subjects (Llamas et al.,
2012) the preservability of epigenetic readings seemed secured,
if the DNA was amplifiable. DNA stability in Post mortem
tissue has been investigated extensively already (Bär et al., 1988;
El-Harouny et al., 2008). Studies by Barrachina and Ferrer et al.
describe the preserved epigenetic analysis quality of brain tissue
up to a PMI of 48 h (simulated) for two genes (Barrachina
and Ferrer, 2009) as well as the general ambiguity involved
with the already mentioned interindividuality of samples in
respect to protein, RNA and DNA degradation (Ferrer et al.,
2008). Large-scale epigenetic studies are also performed in
human post mortem brain tissue as well as comparative studies
to investigate similarities and differences between blood and
brain (Rollins et al., 2010; Wockner et al., 2014). While these
studies provide information about DNA quality they not always
refer to respective PMI timepoints. We were curious whether
there might be differences in the determination of methylation
results that limit such approaches. For the collection of new post
mortem collectives it would also be beneficial to have a fast assay
that provides first evidence for the analysis of reliable data while
extending the PMI window as far as possible.
We therefore decided to perform a longitudinal pilot study
where blood and brain tissue was kept at ambient temperatures
and frozen at distinct timepoints. We observed a correlation
for the progression of DNA degradation both on the level
of macroscopic DNA and on the readouts of the epigenetic
analysis from typical target genes in the field of psychiatry and
neurology, the serotonin transporter gene (SLC6A4) promoter
(Philibert et al., 2008; Vijayendran et al., 2012; Abdolmaleky
et al., 2014) or aldehyde dehydrogenase 2 (ALDH2) (Ikawa
et al., 1983; Kimura et al., 2009; Xue et al., 2012). To reaffirm
the quality estimation method established here we compared
the pig brain data with actual samples from an ongoing
post mortem trial with known post mortem intervals. We
thereby report a first indication for the possible impact DNA
stability has on the analysis of epigenetic phenomena in post
mortem cohorts.
Materials and Methods
Collection and Processing of Porcine Samples
Heads as well as blood from sacrificed pigs (see Table 1) were
immediately retrieved from the Department of Cardiothoracic,
TABLE 1 | Age and weight of the pigs used for the longitudinal
investigation.
Animal Age (months) Weight (kg)
P1 2, 5 22, 6
P2 4, 5 61
Transplantation and Vascular Surgery, Hannover Medical
School, Hannover, Germany. The head was removed for
transport on ice within 30min after death. The animals included
were not older than 4 months to avoid bias through age- related
DNA damage. Within 1 h post mortem, the skullcap was opened
to allow access to the brain for sample asservation. The lid of the
skull was retained to be able to close the head again and thereby
keep the influence of the opening as minimal as possible. The
head was stored at 19–21◦C room temperature. All the samples
were extracted from the Frontal gyri of the porcine cerebrum
with a sharp scalpel. The weight varied between 20 and 50mg
while cutting depth was less than 1 cm, thereby ensuring not to
extract other regions than cerebrum and maintain comparability
of samples. Time Point 0 depicts the time 1 h after the actual
removal of the head, when the first sample of pig cortex was
frozen at −80◦C together with blood aliquots. At 0, 2, 4, 8,
12, 24, 44, 72, 96, and 120 h post mortem cortex samples were
frozen together with heparin-treated blood aliquots prepared
within the first hour post mortem. From timepoint 6 (24 h) on
the removal of samples was ±2 h. The first pig included more
timepoints for measurement (20, 30, see Figure 1A), which were
not included for the second pig. We decided not to cut out the
respective columns from picture 1A but removed them from
further analyses in order to merge methylation data points with
the second animal.
Collection and Processing of Human Samples
Human samples were collected at the Department of Legal
Medicine, Hannover Medical School. The local ethics committee
approved the collection of samples that were collected during
the standard mandatory autopsy performed to exclude
homicide and clarify the cause of death (approval #1127-
2011, Hannover Medical School, Hannover, Germany). The
six brain regions collected were: nucleus arcuatus, nucleus
accumbens, corpus amygdalum, corpus mamillarium, ventral
tegmental area, and the dorsal hippocampus. Subject age,
lifestyle, cause of death and PMI vary significantly (see
Table 2).
DNA Isolation and Bisulfite Reaction
DNA was purified through standard techniques [Trizol, VWR,
Radnor, USA; automated DNA cleanup using Nucleomag bead
kit from Macherey&Nagel, Düren, Germany on a Biomek
NxP pipetting robot (Beckman Coulter, Brea, USA)]. Bisulfite
conversion of DNA samples then were bisulfite-converted
and purified by the EpiTect R© 96 Bisulfite Kit (QIAGEN
AG, Hilden, Germany) according to the manufacturer’s
recommendations.
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FIGURE 1 | Longitudinal pig trial. (A) DNA was isolated from pig brain
tissue frozen at timepoints depicted and separated on a 0.7% agarose
gel. Degraded DNA was put in relation to total DNA in the respective lane
for normalization. (B) The respective graphical display of the increasing
degradation ratio (degraded DNA/total DNA) and (C) likewise increasing
variance of methylation data plotted against PMI were analyzed via linear
regression. Variance was calculated from methylation analysis of brain
cortex DNA (n = 2, means of 8 CpGs in the regions analyzed). These two
resulting values are then correlated in (D) via linear regression,
demonstrating a positive correlation between relative amount of degraded
DNA and variance of methylation. (E) Finally, mean methylation is plotted
against respective PMI for the two tissues analyzed. All black lines
represent the linear function the statistics are based upon while grey lines
represent 95% CI. The error bars in (E) are ±SEM.
DNA Gel Preparation
After determining DNA concentration using a Nanodrop
(Peqlab/ VWR, Radnor, USA) 250 ng DNA from each sample
was loaded onto a 0.7% agarose gel containing 0.004% ethidium
bromide (AppliChem, Gatersleben, Germany) together with
3µl 100 kb DNA ladder (VWR, Radnor, USA) and separated
at 100V constant for 45min at room temperature and a
picture taken with a Geldoc XR+ molecular imaging system
(Bio-Rad Laboratories, Hercules, USA). Relative quantification
was calculated dividing equal area values of genomic DNA
degradation smear with the respective total amount of DNA in
the lane, resulting in a ratio of % degenerated DNA compared to
total DNA that could then be compared across samples and time
points (ImageLab software 5.2; Bio-Rad Laboratories, Hercules,
USA) (see Figure 1A, upper/lower region of the respective
lanes).
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TABLE 2 | Biometrical data for the human collective that was investigated.
Patient# Alcohol
abuse
Sex Age Treatment PMI Smoker
2 No Male 45 None 40 No
3 Yes Male 47 Chlorproxithem,
Oxazepam
68 Yes
5 Yes Female 56 Blood pressure,
analgetics
52 N.A.
11 No Female 60 Intensive care 47 N.A.
12 No Male 63 Blood pressure 38 N.A.
13 Yes Male 57 N.A. 52 Yes
Bisulfite Conversion of DNA, PCR Strategy and
Sequencing
Bisulfite sequence primers were designed using the software
packages MethylPrimer Express (ABI Life Technologies, Grand
Island, USA), Geneious (Biomatters, Auckland, New Zealand)
and the Netprimer tool (PREMIER Biosoft International, Palo
Alto, USA) for validation of different melting temperatures.
Primers were ordered from Metabion (Steinkirchen, Germany).
Touchdown PCRs (Korbie and Mattick, 2008) with starting
temperatures of 70◦C (ALDH2) and 62◦C (SLC6A4),
respectively, were performed using a semi-nested strategy
and sequenced on a 3500XL genetic analyzer from ABI Life
Technologies (Grand Island, USA) (see Table 3 for primer
details).
Analysis of CpG-specific methylation percentage was
processed by the Epigenetic Sequencing Methylation (ESME)
analysis software (Lewin et al., 2004) and the methylation rate
(%) of each CpG site within the amplified region was estimated
by the ratio between normalized peak values of Cytosine (C) and
Thymine (T).
Statistical Analysis
All statistical calculations were performed using IBM Software
Package for the Social Sciences (SPSS, IBM, Armonk, USA)
or Prism 6 (Graphpad, LaJolla, USA). Residuals were assessed
for normality within each group using the Shapiro-Wilk
(W) goodness-of-fit test. Methylation measurements deviated
significantly from normality, shifting the analysis to non-
parametric tests. Positions with less than 70% coverage were
excluded from analysis.
Calculation of variance follows the formula var = mean[(x –
mean(x))∧2]. All values for variance were calculated in SPSS.
Residuals for both degradation [W(10) = 0.531,
p = 0.009] and variance [W(10) = 0.163, p = 0.015]
of pig brain samples did not deviate from normality, in
consequence we applied the Pearson correlation test. Linear
regression was then performed without permutation of
values, since we expected a direct interaction between both
parameters.
Human methylation data was tested for significant differences
between pooled brain measurements for each patient via the
Student’s t-test and found equal according to Tukeys correction
for multiple comparisons.
TABLE 3 | Primers used for the Touchdown PCRs.
Primer name Sequence Fragment size
ALDH2-F2_NEU GAGGTATGGTTGTGTGATTG 258 bp
ALDH2-F1_NEU TTTGGTGTTGAAATTAGAGTT
ALDH2_RC1_NEU ACTCACTACAAACTCTACCTCC





DNA Degradation Series in Pig Blood and Brain
In the porcine brain samples we were able to detect the
progressing degradation of DNA by standard gel electrophoresis
and semi-quantification of incremental increase of sheared DNA
in the sample (Figures 1A,B). This degradation curve was not
identically reproducible in the blood samples as well as not
reproducible in the second pig analyzed due to interindividual
differences in the degradation kinetics (data not shown),
although time-dependent progression was visible (Compare to
Figure S1).
Methylation Analysis of Pig Blood and Brain
Samples
For the two animals investigated, in addition to the progressing
macroscopical changes observed during gel electrophoresis, we
noted an increase in variance of mean methylation percentage
with advancing timepoints (See Figure 1C, R2 = 0.3966, p =
0.051). Pearson correlation of the parametric variables showed
robust significance between the two parameters (F = 9.595, R2 =
0.545, p = 0.0147) the mean variance of brain measurements
of the two subjects analyzed plotted against the degradation
values calculated from the DNA gel shows a good correlation
(Figure 1D, R2 = 0.431, p = 0.0392) of data points. We also
tested blood samples for the according comparison, but while the
DNA gel picture showed similar degradation patterns, the gel was
not quantifiable in the way the brain samples have been (data
not shown). This is supposedly due to the artificial storage of the
blood aliquots in vials rather than in the corpse, thereby altering
the natural exposure to degradation processes. However, upon
calculating the variance for the epigenetic results, we were able
to equally correlate these values to the progress of degradation
observed in brain tissue (Figure S1, F = 5.422, p = 0.0483,
R2 = 0.4040).
Across all samples generated at all timepoints, the methylation
rate measurements did not vary significantly from each other
(Figure 1E, see also Figure S3). Some of the CpG positions
were harder to sequence, but this deviation is consistent across
all the timepoints pointing toward unknown interindividual
differences (data not shown). Since single CpG positions were
equally affected by the degradation phenomenon, we decided to
limit our analysis to the change observed in the whole region (see
Figure S2).
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FIGURE 2 | (A) DNA gel electrophoresis for 3 of the six human subjects
analyzed for comparison. Degraded DNA was put in relation to total DNA in
the respective lane for normalization. (B) Epigenetic variance of the ALDH2
gene for timepoints investigated in human DNA is stable both between blood
and brain as well as in regards to variance of measurements. The mean
methylation rate (%) of 10 CpGs of 6 brain regions was calculated for 5 post
mortem subjects and is plotted against respective PMI for the two tissues
analyzed. All error bars are ±SEM.
DNA Degradation Test in Human Brain Regions
and Blood
In an ongoing post mortem trial we are collecting blood and brain
samples from 6 different regions. These subjects vary strongly in
all parameters assessed (see Table 2 in Materials and Methods)
and were selected for covering the range of PMIs collected
until now (38–68 h). DNA degradation displayed a much more
diverse picture compared to the pig trial data, which reflects the
highly individual gender, origin, lifestyle, pathologies, cause of
death, and environmental circumstances at the site of death (see
Figure 2A). However, epigenetic measurements show only small
deviations from the methylation rate (%) for both blood and the
different brain regions (not significant), proving the integrity of
samples collected within this PMI range (Figure 2B).
Discussion
DNA is an amazingly resistant molecule. From forensics to
archeology this feature is the key factor necessary to recollect
information from degraded tissue of any kind, utilizing the
information conserved in this resilient molecule (Wockner et al.,
2014). Most astoundingly, even in selected cases of archeological
samples methylation analysis is possible if the material can be
amplified (Llamas et al., 2012). In this study we wanted to
determine the validity of such investigations in a longitudinal
setup to ensure the precision of data recovered is also true for
highly variable regions of methylation. While the influence of
PMI on epigenetic measurements has already been investigated
(Barrachina and Ferrer, 2009), we were curious to see whether
there will be an observable influence when the PMI is increased
to the point where a safe extraction of individual regions is no
longer possible due to tissue degradation. Our first observation
was actually backing up the findings of previous authors in terms
of consistency, as we were not able to detect any significant time-
dependent effect of the mean epigenetic readouts themselves.
Noting a visible increase in the deviation error bars, we decided
to test for change in variance. With differences between cohorts
seldom yielding results above 5–20% methylation, an increase
in sample deviation could potentially lead to false interpretation
of observed effects. We therefore calculated the mean variance
for the brain analysis from the two subjects and plotted the
resulting data against the normalized degradation values from the
gel. Most interestingly these values correlate significantly (p =
0.0147) and provide a statistical explanation for 43% of cases
(Figure 1D). Therefore, the influence of PMI for the timeframe
of investigation not only proves the connection of measurement
quality with the amount of degradation but also that PMI
and methylation variance play an essential role in the fidelity
of data measured. Since both degradation and methylation
variance increased with timepoint 8 (72 h) we decided to take
the respective calculated degradation ratio as a threshold for
our sample collection in the ongoing post mortem trial. Also
our suggested degradation ratio seems to suggest a ratio of 40%
as a tentative threshold for DNA quality. However, taking the
variability of the results for different tissues into account, we need
to prove this assumption in further experiments.
To see whether our DNA quality prediction holds true, we
analyzed 6 human subjects for blood and brain degradation
in perspective of their estimated PMIs. Since only samples
from timepoints below 72 h PMI were collected, we do not
have a comparable PMI included for the other timepoints
generated in the pig trial. Region-specific differences of DNA
degradation are expected to be a multifactorial phenomenon
influenced not only by PMI, but also lifestyle influences, cause
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of death and environmental conditions. The samples therefore
reveal individual patterns concerning degradation ormethylation
variance. In spite of these factors both blood and brain sample
methylation varied only in small degrees from the global mean
in both value and variance, reaffirming overall tissue quality to
still provide reliable data. We also observed small tissue-specific
methylation differences for ALDH2 between blood and brain,
pointing toward the translational capacities for investigation of
this locus in larger patient studies for a potential prognostic value
in diagnosis and therapy (Figure 2B).
There are a couple of limitations to this study that narrow the
scope of interpretation of these findings. The number of included
subject, counting two for the pig experiment and 6 for the human
post mortem cohort needs replication as sample size only allows
for preliminary interpretations. It is remarkable though that
even for these small cohort sizes, methylation analysis displays
only small interindividual variation and a significant trend in
methylation variance in the pig brain samples (Figure 1C). The
limitation to cortex tissue in the pig trial is partly compensated
statistically by the analysis of six regions in the human subjects,
creating technical duplicates. A specific degradation resulting
from unavoidable continued exposure to air during the different
PMI timepoints of the pig trial is also introducing trial-specific
artifacts. Observing the general effect variance dependence on
PMI, we are planning to follow up this pilot study with an
investigation of this phenomenon in a genome-spanning setting.
While we believe to observe a general phenomenon based
on investigation of genuinely different tissues and two genes
involved in different metabolic processes (alcohol metabolism
and neuronal signal transmission), as of now it cannot be ruled
out that the effect is limited to these specific loci.
This holds true for blood methylation levels as well
when related to the brain degradation values calculated for
the respective timepoints. Analysis of epigenetic variance
in pig blood suggests equal correlations in terms of time-
related decrease in quality (Figure S1). While the effect of
extracorporal storage of heparinized blood is to be taken
into account, comparing the degradation patterns for blood
and brain in human samples (Figure 2A) suggests that tissue-
specific degradation thresholds need to be determined for gel
electrophoresis. However, observing the strong variation of DNA
quality in different tissues, the measurement in one specific
region cannot be extrapolated on the whole subject, thereby
potentially complicating DNA quality assessment.
Since the effect of degradation should be visible throughout
the different tissues and genes and the human data is only
a confirmatory test, we decided to take the available human
ALDH2 gene information for comparison. We also had a good
indication that variance for ALDH2 methylation is minimal in
freshly obtained blood samples from previous human studies.We
nevertheless cannot rule out the possible predisposed difference
in variance between genes to influence the data displayed.
We hereby describe for the first time that epigenetic
measurements are potentially influenced by PMI. In the process
though, with DNA degradation we also discovered a simple way
to ensure integrity of DNA quality from post mortem tissue that
is able to predict variance of epigenetic data and therefore limit
misleading interpretation of data generated by this technique.
It is most likely that this finding impacts other techniques for
measuring epigenetic phenomena, including next generation
sequencing approaches. The impact of such a quality regimen
is enormous, given that epigenetic differences discriminating
conditions can very likely be in the range of 5–15% methylation
difference. Further experiments will be needed to ensure the
overall robustness of this method, but we are confident that
elimination inconsistencies in epigenetic analyses will be highly
improved by applying the findings presented here.
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Figure S1 | Pig blood methylation variance is plotted against the
degradation values derived from the semiquantitative degradation scale
in pig brain. Irrespective of interindividual tissue degradation patterns methylation
variance in blood samples leads to strong correlation (R2 = 0.596, p = 0.0089).
The dashed line represents 95% CI.
Figure S2 | Epigenetic measurements split up for tissue and individual
animals on the 10 timepoints that were identical for both subjects. This
data is merged in Figure 1E. P1 and P2 describe the individual pigs investigated
for the individual timepoints. Error bars (±SEM) resulted from merging sequencing
data of the 8 CpGs in the promoter stretch −1396 to −1016 in relation to the
transcription start site of porcine SLC6A4 (Ensembl).
Figure S3 | Display of single CpG methylation pattern for Blood (A) and
Brain (B) of the SLC6A4 gene promoter in the pig trial study. Not seeing any
meaningful difference between CpG methylation variance, we decided to compare
global values instead of individual alterations. CpG 4 was excluded from this
display as well as from analysis due to bad sequencing quality.
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